Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.

Activation of endothelial cells by lipid oxidation products is a key event in the initiation and progression of the atherosclerotic lesion. Minimally modified low-density lipoprotein (MM-LDL) induces the expression of certain inflammatory molecules such as tissue factor (TF) in endothelial cells. This study examined intracellular signaling pathways leading to TF up-regulation by oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (OxPAPC), a biologically active component of MM-LDL. OxPAPC induced TF activity and protein expression in human umbilical vein endothelial cells (HUVECs). However, OxPAPC neither induced phosphorylation or degradation of I kappa B alpha nor DNA binding of nuclear factor-kappa B (NF-kappa B). Furthermore, OxPAPC-induced TF expression was not inhibited by overexpression of I kappa B alpha. These results strongly indicate that OxPAPC-induced TF expression is independent of the classical NF-kappa B pathway. However, OxPAPC stimulated phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 and expression of early growth response factor 1 (EGR-1). Inhibitors of mitogen-activated kinase/ERK (MEK) or protein kinase C (PKC) blocked elevation of both EGR-1 and TF. Furthermore, overexpression of NAB2, a corepressor of EGR-1, inhibited effects of OxPAPC. In addition, OxPAPC induced rapid and reversible elevation of free cytosolic Ca(++) levels and nuclear factor of activated T cells (NFAT)/DNA binding. Induction of TF expression by OxPAPC was partially inhibited by cyclosporin A, known to block calcineurin, a Ca(++)-dependent phosphatase upstream of NFAT. Treatment of OxPAPC with phospholipase A(2) destroyed its biologic activity and 1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphorylcholine was identified as one biologically active component of OxPAPC that induces TF expression. Together, the results demonstrate that OxPAPC induces TF expression in HUVECs through activation of PKC/ERK/EGR-1 and Ca(++)/calcineurin/NFAT pathways rather than by NF-kappa B-mediated transcription. Thus, oxidized phospholipids may contribute to inflammation by activating pathways alternative to the classical NF-kappa B pathway.

[1]  R. Bach.  Initiation of Coagulation by Tissue Facto , 1988 .

[2]  A. Manning,et al.  Multiple signals converging on NF-kappaB. , 1999, Current opinion in cell biology.

[3]  E. Silverman,et al.  Pathways of Egr-1-mediated gene transcription in vascular biology. , 1999, The American journal of pathology.

[4]  R. Bach.  Initiation of coagulation by tissue factor. , 1988, CRC critical reviews in biochemistry.

[5]  B. Ohlsson,et al.  Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages. , 1996, The Journal of clinical investigation.

[6]  Y. Pak,et al.  Role of endocytosis in the transactivation of nuclear factor-κB by oxidized low-density lipoprotein , 2000 .

[7]  Y. Pak,et al.  Role of endocytosis in the transactivation of nuclear factor-kappaB by oxidized low-density lipoprotein. , 2000, Biochemical Journal.

[8]  Kathleen M. Smith,et al.  Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Frieden,et al.  Subplasmalemmal ryanodine‐sensitive Ca2+ release contributes to Ca2+‐dependent K+ channel activation in a human umbilical vein endothelial cell line , 2000, The Journal of physiology.

[10]  Hans Lee,et al.  Determinants of Bioactivity of Oxidized Phospholipids: Specific Oxidized Fatty Acyl Groups at the sn-2 Position , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[11]  B. Binder,et al.  Specificity, diversity, and convergence in VEGF and TNF‐α signaling events leading to tissue factor up regulation via EGR‐1 in endothelial cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  N. Mackman.  Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  P. Cohen.  Dissection of protein kinase cascades that mediate cellular response to cytokines and cellular stress. , 1996, Advances in pharmacology.

[14]  Haihua,et al.  Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. , 1991, The American journal of pathology.

[15]  B. Engelmann,et al.  Tissue factor expression of human monocytes is suppressed by lysophosphatidylcholine. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[16]  J. Mehta,et al.  γ-Tocopherol Decreases Ox-LDL-Mediated Activation of Nuclear Factor-κB and Apoptosis in Human Coronary Artery Endothelial Cells , 1999 .

[17]  J. Major,et al.  Oxidized LDL modulates activation of NFκB in mononuclear phagocytes by altering the degradation of IκBs , 1998 .

[18]  B. Binder,et al.  Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. , 1999, Blood.

[19]  N. Mackman,et al.  Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Cybulsky,et al.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.

[21]  S. Pan,et al.  Activation of mitogen-activated protein kinase by oxidized low-density lipoprotein in canine cultured vascular smooth muscle cells. , 2000, Cellular signalling.

[22]  A. Kolstø,et al.  Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.

[23]  J. Gutkind.  The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades* , 1998, The Journal of Biological Chemistry.

[24]  Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B , 1996, The Journal of experimental medicine.

[25]  A. Manning,et al.  Multiple signals converging on NF-κB , 1999 .

[26]  S. Pizzo,et al.  Oxidized Low Density Lipoprotein Suppresses Activation of NFκB in Macrophages via a Pertussis Toxin-sensitive Signaling Mechanism (*) , 1995, The Journal of Biological Chemistry.

[27]  M. Sturek,et al.  Submaximal stimulation of porcine endothelial cells causes focal Ca2+ elevation beneath the cell membrane , 1998, The Journal of physiology.

[28]  B. Berk,et al.  NAB2: a transcriptional brake for activated gene expression in the vessel wall? , 1999, The American journal of pathology.

[29]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[30]  J. Mehta,et al.  gamma-tocopherol decreases ox-LDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells. , 1999, Biochemical and biophysical research communications.

[31]  J. Fallon,et al.  In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[32]  Wei Sha,et al.  Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.

[33]  J. Berliner,et al.  Structural Identification of a Novel Pro-inflammatory Epoxyisoprostane Phospholipid in Mildly Oxidized Low Density Lipoprotein* , 1999, The Journal of Biological Chemistry.

[34]  C. Glass,et al.  Mildly Oxidized Low Density Lipoprotein Activates Multiple Apoptotic Signaling Pathways in Human Coronary Cells , 2022 .

[35]  A. Alfranca,et al.  Up-regulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1. , 2000, Blood.

[36]  C. Dinarello,et al.  Proinflammatory cytokines. , 2000, Chest.

[37]  G. Henkel,et al.  Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex , 1996, Molecular and cellular biology.

[38]  A. Dickmanns,et al.  Nucleocytoplasmic Shuttling Factors Including Ran and CRM1 Mediate Nuclear Export of NFAT In Vitro , 1998, The Journal of cell biology.

[39]  J. Redondo,et al.  Vascular Endothelial Growth Factor Activates Nuclear Factor of Activated T Cells in Human Endothelial Cells: a Role for Tissue Factor Gene Expression , 1999, Molecular and Cellular Biology.

[40]  A. Chait,et al.  Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[41]  J. Berliner,et al.  MM-LDL and Atherogenesis — A Major Role for Phospholipid Oxidation Products , 2000 .

[42]  F. Bach,et al.  Regulation of the Tissue Factor Promoter in Endothelial Cells , 1995, The Journal of Biological Chemistry.

[43]  C. Slaughter,et al.  ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation. , 1995, The EMBO journal.

[44]  G. Crabtree,et al.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A , 1991, Nature.

[45]  M. Penn,et al.  Native and Oxidized Low Density Lipoprotein Induction of Tissue Factor Gene Expression in Smooth Muscle Cells Is Mediated by Both Egr-1 and Sp1* , 1999, The Journal of Biological Chemistry.

[46]  K. Xu,et al.  Histamine induces nuclear factor of activated T cell-mediated transcription and cyclosporin A-sensitive interleukin-8 mRNA expression in human umbilical vein endothelial cells. , 1998, Molecular pharmacology.